| 1 |
2022 |
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness. |
--- |
| 2 |
2022 |
A Needle in a Haystack? Human Rights Framing at the World Trade Organization for Access to COVID-19 Vaccines. |
--- |
| 3 |
2022 |
A novel machine learning approach to predict the export price of seafood products based on competitive information: The case of the export of Vietnamese shrimp to the US market. |
FAO, SHAP |
| 4 |
2022 |
Access to COVID-19 Vaccines: A New Global Approach. |
COVID-19, IHR, IP, WHO |
| 5 |
2022 |
Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching. |
CST |
| 6 |
2022 |
Does technology innovation matter for environmental pollution? Testing the pollution halo/haven hypothesis for Asian countries. |
ARDL |
| 7 |
2022 |
Export Expansion May Increase Adult Illness and Injury: A Quasi-Natural Experiment on China's Accession to the World Trade Organization. |
AE, AE |
| 8 |
2022 |
From OIE standards to responsible and prudent use of antimicrobials: supporting stewardship for the use of antimicrobial agents in animals. |
AMR, AMU, GAP, OIE, PVS |
| 9 |
2022 |
Has the Spread of African Swine Fever in the European Union Been Impacted by COVID-19 Pandemic? |
ASF, OIE |
| 10 |
2022 |
Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders. |
--- |
| 11 |
2022 |
Industry influence over global alcohol policies via the World Trade Organization: a qualitative analysis of discussions on alcohol health warning labelling, 2010-19. |
TBT |
| 12 |
2021 |
Are WTO Decisionmakers Regulating Technological Risks or Are Technological Risks Steering WTO Biotechnology Legal Decisions? |
--- |
| 13 |
2021 |
Autonomy and international organisations. |
IOs, P-A, WHO |
| 14 |
2021 |
COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform. |
GHD, IPRs, TRIPS |
| 15 |
2021 |
Does TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) prevent COVID-19 vaccines as a global public good? |
ACT, WHA |
| 16 |
2021 |
Global health diplomacy at the intersection of trade and health in the COVID-19 era. |
COVID-19, TRIPS |
| 17 |
2021 |
Globalization and environment: Effects of international trade on emission intensity reduction of pollutants causing global and local concerns. |
--- |
| 18 |
2021 |
Globalization and working conditions in international supply chains. |
EPZ, ILO, SEZ |
| 19 |
2021 |
Glossary on free trade agreements and health part 1: the shift from multilateralism and the rise of 'WTO-Plus' provisions. |
FTAs |
| 20 |
2021 |
Glossary on free trade agreements and health part 2: new trade rules and new urgencies in the context of COVID-19. |
FTAs |
| 21 |
2021 |
Neoliberal discourse, actor power, and the politics of nutrition policy: A qualitative analysis of informal challenges to nutrition labelling regulations at the World Trade Organization, 2007-2019. |
HICs, LMICs, TBT |
| 22 |
2021 |
Role of trade openness, export diversification, and renewable electricity output in realizing carbon neutrality dream of China. |
--- |
| 23 |
2021 |
The impact of preferential trade agreements on bilateral trade: A structural gravity model analysis. |
GVCs, MRIO, PTAs |
| 24 |
2021 |
What You Don't Know About the Codex Can Hurt You: How Trade Policy Trumps Global Health Governance in Infant and Young Child Nutrition. |
CAC, CMFs, CSFUF, WHO |
| 25 |
2021 |
What's yours is ours: waiving intellectual property protections for COVID-19 vaccines. |
IP |
| 26 |
2020 |
Animal welfare in the context of World Trade Organization dispute settlement. |
OIE |
| 27 |
2020 |
Building capacity for World Trade Organization dispute settlement: piloting polarity mapping for trade relations. |
--- |
| 28 |
2020 |
Call for international cooperation and collaboration to effectively tackle the COVID-19 pandemic. |
WHO |
| 29 |
2020 |
Changes in alcoholic beverage preference and consumption in Taiwan following accession to the World Trade Organization. |
aRR, CI, NAHSIT, PRR |
| 30 |
2020 |
Changing the narrative on fisheries subsidies reform: Enabling transitions to achieve SDG 14.6 and beyond. |
SDG |
| 31 |
2020 |
Disease-free zones: bilateral recognition procedure in South America. |
OIE |
| 32 |
2020 |
Facilitating market access: risk assessment, equivalence and regionalisation provisions in the Agreement on the Application of Sanitary and Phytosanitary Measures. |
--- |
| 33 |
2020 |
Harnessing trade and investment agreements to promote public health. |
FTA, GATT, ISDS |
| 34 |
2020 |
Hollow Threats: Transnational Food and Beverage Companies' Use of International Agreements to Fight Front-of-Pack Nutrition Labeling in Mexico and Beyond. |
FoPNL, NAFTA, TFBCs, USMCA |
| 35 |
2020 |
Implementation of OIE international standards: challenges and opportunities for monitoring. |
OIE, PVS, WAHIS |
| 36 |
2020 |
International regulatory cooperation: contribution of the OIE and the WTO Agreement on the Application of Sanitary and Phytosanitary Measures and SPS Committee. |
OIE |
| 37 |
2020 |
The impact of natural disasters on China's macroeconomy. |
SUR, SVAR |
| 38 |
2020 |
The World Trade Organization Agreement on the Application of Sanitary and Phytosanitary Measures and veterinary control procedures. |
--- |
| 39 |
2020 |
World Trade Organization disputes related to animal diseases. |
OIE |
| 40 |
2019 |
Brexit and Animal Welfare Impact Assessment: Analysis of the Opportunities Brexit Presents for Animal Protection in the UK, EU, and Internationally. |
CAP, EU, PETS, UK |
| 41 |
2019 |
Development of model web-server for crop variety identification using throughput SNP genotyping data. |
ABS, DUS, IPR, PBR |
| 42 |
2019 |
International Trade and Health Care in Brazil: An Unpredicted Tale Threatening Health Care Entitlement? |
GATS |
| 43 |
2019 |
Linkages between Trade, CO2 Emissions and Healthcare Spending in China. |
--- |
| 44 |
2019 |
Trade of aquatic animals and aquatic animal products: the use of OIE international standards for devising sanitary measures. |
OIE |
| 45 |
2019 |
World Trade Organization membership and changes in noncommunicable disease risk factors: a comparative interrupted time-series analysis, 1980-2013. |
--- |
| 46 |
2018 |
'Bioexit': navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape. |
EEA, EU |
| 47 |
2018 |
Global governance and the broader determinants of health: A comparative case study of UNDP's and WTO's engagement with global health. |
UNDP |
| 48 |
2018 |
Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016. |
--- |
| 49 |
2018 |
Trade challenges at the World Trade Organization to national noncommunicable disease prevention policies: A thematic document analysis of trade and health policy space. |
NCDs |
| 50 |
2017 |
An International Model for Antibiotics Regulation. |
OIE |
| 51 |
2017 |
Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging. |
MNEs |
| 52 |
2017 |
Thinking Out of the Box: A Green and Social Climate Fund Comment on "Politics, Power, Poverty and Global Health: Systems and Frames". |
--- |
| 53 |
2016 |
Implementing Intellectual Property of Pharmaceuticals in Middle-Income Countries: A Case Study of Patent Regulation in Brazil. |
IP |
| 54 |
2016 |
Rhetoric and the law, or the law of rhetoric: How countries oppose novel tobacco control measures at the World Trade Organization. |
--- |
| 55 |
2016 |
ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS. |
UN, UNODC, WCO, WHO, WIPO |
| 56 |
2016 |
Support for international trade law: The US and the EU compared. |
PTAs |
| 57 |
2016 |
The Trans-Pacific Partnership and pharmaceutical innovation. |
IPR, RDP, TPP |
| 58 |
2015 |
The scientific rationale for the World Organisation for Animal Health standards and recommendations on avian influenza. |
OIE, Terrestrial Code |
| 59 |
2015 |
Tobacco control and the World Trade Organization: mapping member states' positions after the framework convention on tobacco control. |
FCTC, GATT, TBT, TRIPS |
| 60 |
2015 |
[Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights]. |
ICESCR, TRIPS |
| 61 |
2014 |
Access to medicines and distributive justice: breaching Doha's ethical threshold. |
NCDs |
| 62 |
2014 |
Assessment of the association of health with the liberalisation of trade in services under the World Trade Organisation. |
GATS, LE, MM, PEH, U5M |
| 63 |
2014 |
Compulsory patent licensing and local drug manufacturing capacity in Africa. |
--- |
| 64 |
2014 |
Evolving norms at the intersection of health and trade. |
--- |
| 65 |
2014 |
Exploring risk judgments in a trade dispute using Bayesian networks. |
BNs, IRA |
| 66 |
2014 |
The plights of African resources patenting through the lenses of the World Trade Organisation: an assessment of South Africa's rooibos tea's labyrith journey. |
ARIPO, ASB, GIs, IK, IPRs, MNCs, PIC, TWSs |
| 67 |
2013 |
A study on the transfer of heavy methals released by Chinese commercial products. |
OECD |
| 68 |
2013 |
Animal Disease Import Risk Analysis--a Review of Current Methods and Practice. |
IRA, OIE, SPS |
| 69 |
2013 |
Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study. |
cGMP, IP, WHO |
| 70 |
2013 |
Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA. |
TPPA |
| 71 |
2013 |
How do international trade obligations affect policy options for obesity prevention? Lessons from recent developments in trade and tobacco control. |
--- |
| 72 |
2013 |
The challenges of disease risk ascertainment using accessible data sources for numbers of travelers. |
MDR |
| 73 |
2013 |
Trade liberalization and tuberculosis incidence: a longitudinal multi-level analysis in 22 high burden countries between 1990 and 2010. |
CI, HDI, TB |
| 74 |
2012 |
Australia's double standard on Thailand's alcohol warning labels. |
--- |
| 75 |
2012 |
How does the World Trade Organization know? The mobilization and staging of scientific expertise in the GMO trade dispute. |
SPS |
| 76 |
2012 |
How to model a negligible probability under the WTO sanitary and phytosanitary agreement? |
--- |
| 77 |
2012 |
The Food Safety Modernization Act: a barrier to trade? Only if the science says so. |
--- |
| 78 |
2012 |
The new patent regime and disease priorities in India. |
TRIPS |
| 79 |
2012 |
The role of intellectual property rights in treatment access: challenges and solutions. |
TRIPS |
| 80 |
2012 |
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis. |
CLs, UMICs |
| 81 |
2012 |
World Trade Organization activity for health services. |
GATS |
| 82 |
2011 |
Implications of the World Trade Organization in combating non-communicable diseases. |
WHO |
| 83 |
2011 |
Risk analysis and its link with standards of the World Organisation for Animal Health. |
OIE |
| 84 |
2011 |
The spread of pathogens through trade in honey bees and their products (including queen bees and semen): overview and recent developments. |
--- |
| 85 |
2010 |
A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime. |
CAMR |
| 86 |
2010 |
International cooperation in the solution to trade-related invasive species risks. |
IHR |
| 87 |
2010 |
The role of the World Trade Organization and the 'three sisters' (the World Organisation for Animal Health, the International Plant Protection Convention and the Codex Alimentarius Commission) in the control of invasive alien species and the preservation of biodiversity. |
CAC, IAS, IPPC, OIE |
| 88 |
2009 |
Bridging the divide: global governance of trade and health. |
GATT |
| 89 |
2009 |
Government regulation of pricing and reimbursement of prescription medicines: results of a recent multi-country review. |
EU |
| 90 |
2009 |
The potential impact of the World Trade Organization's general agreement on trade in services on health system reform and regulation in the United States. |
--- |
| 91 |
2009 |
The role of the World Organisation for Animal Health (OIE) to facilitate the international trade in animals and animal products. |
OIE |
| 92 |
2009 |
Trade and health: an agenda for action. |
--- |
| 93 |
2008 |
First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime. |
--- |
| 94 |
2008 |
International jurisprudence on trade and environmental health: one step forward, two steps back? |
MEAs |
| 95 |
2008 |
Trade and health: how World Trade Organization (WTO) law affects alcohol and public health. |
--- |
| 96 |
2007 |
Agricultural science and food policy for consumers and workers: recipes for public health successes or disasters? |
NGOs |
| 97 |
2007 |
British American Tobacco's tactics during China's accession to the World Trade Organization. |
BAT, EU |
| 98 |
2007 |
Risk assessment and surveillance for bovine spongiform encephalopathy. |
BSE, OIE |
| 99 |
2007 |
The right to health. |
--- |
| 100 |
2007 |
Trade policy and public goods. |
--- |
A Search Service for Abbreviation / Long Form
